Funder
Kyoto Pharmaceutical University
Japan Society for the Promotion of Science
Japan Agency for Medical Research and Development
Reference40 articles.
1. 5 (Eris) and BA.2.86 (Pirola) two new subvariants of SARS-CoV-2: a new face of old COVID-19;Abdolreza;Infection,2024
2. Neutralization, effector function and immune imprinting of Omicron variants;Addetia;Nature,2023
3. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies;Barnes;Nature,2020
4. Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies;Bruel;Cell Rep. Med,2022
5. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection;Cao;Nature,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献